TTM
97.3%
YoY change
+17.57pp
Trough year (2019)
-30.9%
Peak year (2025)
96.3%
Latest annual
96.3%
Gross Margin history chart for Tango Therapeutics (TNGX) from 2019 to 2025
Latest: 96.3%
Gross Margin change chart for Tango Therapeutics (TNGX) from 2019 to 2025
Latest: +109.71pp
Gross Margin history table for Tango Therapeutics (TNGX) from 2019 to 2025
| 2025 | 96.3% | — | ||
| 2020 | 78.8% | +109.71pp | ||
| 2019 | -30.9% | — |
- 202596.3%—
- 202078.8%+109.71pp
- 2019-30.9%—
Gross Margin values are taken from Tango Therapeutics's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Gross Margin at Tango Therapeutics (TNGX)
According to Tango Therapeutics's latest reported financial statements, the company's latest reported gross margin is 97.3%. Gross margin is gross profit divided by revenue, expressed as a percentage. It shows how much of each sales dollar survives the direct cost of goods sold — before operating expenses, interest, and taxes. A higher gross margin generally signals pricing power and production efficiency. Margins are most meaningful compared against sector peers and a company's own history.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, Tango Therapeutics (TNGX) reported gross margin of 96.34% – expanded 17.6 percentage points year-over-year.
Tango Therapeutics Gross Margin by Year
Tango Therapeutics Gross Margin 2025: 96.3%
Tango Therapeutics gross margin in 2025 was 96.34%, expanded 17.6 percentage points from 2020. This figure represents the highest annual value in the available history.
Tango Therapeutics Gross Margin 2020: 78.8%
2020's gross margin for Tango Therapeutics came in at 78.77%, expanded 109.7 percentage points from 2019.
Tango Therapeutics Gross Margin 2019: -30.9%
Tango Therapeutics gross margin in 2019 was -30.93%.
See more financial history for Tango Therapeutics (TNGX).
Sector peers by Gross Margin
Healthcare peers of Tango Therapeutics (TNGX), ranked by their latest gross margin
| 83.5% | |
| 81.8% | |
| 81.7% | |
| 75.9% | |
| 71.5% | |
| 70.7% | |
| 70.0% | |
| 18.8% |
- 83.5%
- 81.8%
- 81.7%
- 75.9%
- 71.5%
- 70.7%
Frequently asked questions
Tango Therapeutics (TNGX) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation